Cargando…
Immunological profiling as a means to invigorate personalized cancer therapy
Immunotherapy has taken off but has not yet reached its cruising altitude and is certainly far from its final destination. Identifying the unique immunological profile of individual cancer patients will provide critical clues for the design of optimal strategies that rectify tumor-induced immune imb...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805634/ https://www.ncbi.nlm.nih.gov/pubmed/24167762 http://dx.doi.org/10.4161/onci.25236 |
_version_ | 1782477894752141312 |
---|---|
author | Hegmans, Joost PJJ Aerts, Joachim GJV |
author_facet | Hegmans, Joost PJJ Aerts, Joachim GJV |
author_sort | Hegmans, Joost PJJ |
collection | PubMed |
description | Immunotherapy has taken off but has not yet reached its cruising altitude and is certainly far from its final destination. Identifying the unique immunological profile of individual cancer patients will provide critical clues for the design of optimal strategies that rectify tumor-induced immune imbalances. |
format | Online Article Text |
id | pubmed-3805634 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Landes Bioscience |
record_format | MEDLINE/PubMed |
spelling | pubmed-38056342013-10-28 Immunological profiling as a means to invigorate personalized cancer therapy Hegmans, Joost PJJ Aerts, Joachim GJV Oncoimmunology Author's View Immunotherapy has taken off but has not yet reached its cruising altitude and is certainly far from its final destination. Identifying the unique immunological profile of individual cancer patients will provide critical clues for the design of optimal strategies that rectify tumor-induced immune imbalances. Landes Bioscience 2013-08-01 2013-06-10 /pmc/articles/PMC3805634/ /pubmed/24167762 http://dx.doi.org/10.4161/onci.25236 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Author's View Hegmans, Joost PJJ Aerts, Joachim GJV Immunological profiling as a means to invigorate personalized cancer therapy |
title | Immunological profiling as a means to invigorate personalized cancer therapy |
title_full | Immunological profiling as a means to invigorate personalized cancer therapy |
title_fullStr | Immunological profiling as a means to invigorate personalized cancer therapy |
title_full_unstemmed | Immunological profiling as a means to invigorate personalized cancer therapy |
title_short | Immunological profiling as a means to invigorate personalized cancer therapy |
title_sort | immunological profiling as a means to invigorate personalized cancer therapy |
topic | Author's View |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805634/ https://www.ncbi.nlm.nih.gov/pubmed/24167762 http://dx.doi.org/10.4161/onci.25236 |
work_keys_str_mv | AT hegmansjoostpjj immunologicalprofilingasameanstoinvigoratepersonalizedcancertherapy AT aertsjoachimgjv immunologicalprofilingasameanstoinvigoratepersonalizedcancertherapy |